Abstract
The economic evaluation of healthcare interventions is now a prerequisite in many jurisdictions. Adoption of new healthcare interventions cannot only be based on their efficacy and safety. In the context of limited healthcare resources we are facing, their economic impact should also be considered. To estimate the economic impact of health interventions, methods for economic evaluation have been developed and adopted. The main objective of these economic evaluations is to help the healthcare decision makers to select interventions that will support a better allocation of resources.
Alongside the development of different surgical techniques for corneal transplantation, economic evaluations have been performed. The new surgical procedures have improved the clinical performance of corneal transplantation, and in most cases these new interventions were shown to be cost-effective.
Only a few economic evaluations of corneal transplantation techniques have been performed in only a few different countries. Additional economic evaluations are needed to assess the economic impact of these interventions over many more contexts of use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Drummond MF, O’Brien B, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford Medical Publication, Oxford University Press; 2005.
Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. 3rd ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006.
Neyt M, Van Brabandt H. The importance of the comparator in economic evaluations: working on the efficiency frontier. Pharmacoeconomics. 2011;29(11):913–6. doi:10.2165/11595260-000000000-00000.
World Health Organization. Human organ and tissue transplantation. Report by the Secretariat; 2003.
Canadian Blood Services. Demand for ocular tissue in Canada – final report Ottawa; 2010.
EBAA. 2013 Eye banking statistical report. Washington, DC: EBAA; 2014.
Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999;97:473–511.
Brown MM, Brown GC, Sharma S, Busbee B. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003;110(6):1076–81. doi:10.1016/S0161-6420(03)00254-9.
Brown MM, Brown GC, Sharma S, Busbee B, Brown H. Quality of life associated with unilateral and bilateral good vision. Ophthalmology. 2001;108(4):643–7; discussion 7–8.
Tillett CW. Posterior lamellar keratoplasty. Am J Ophthalmol. 1956;41(3):530–3.
Melles GR, Eggink FA, Lander F, Pels E, Rietveld FJ, Beekhuis WH, et al. A surgical technique for posterior lamellar keratoplasty. Cornea. 1998;17(6):618–26.
Melles GR, Lander F, Beekhuis WH, Remeijer L, Binder PS. Posterior lamellar keratoplasty for a case of pseudophakic bullous keratopathy. Am J Ophthalmol. 1999;127(3):340–1.
Melles GR, Lander F, Nieuwendaal C. Sutureless, posterior lamellar keratoplasty: a case report of a modified technique. Cornea. 2002;21(3):325–7.
Melles GR, Lander F, van Dooren BT, Pels E, Beekhuis WH. Preliminary clinical results of posterior lamellar keratoplasty through a sclerocorneal pocket incision. Ophthalmology. 2000;107(10):1850–6; discussion 7.
van Dijk K, Dapena I, Moutsouris K, Ham L, Nieuwendaal C, Melles GR. First DLEK series: 10-year follow-up. Ophthalmology. 2011;118(2):424e1–3. doi:10.1016/j.ophtha.2010.10.006.
van Dooren B, Mulder PG, Nieuwendaal CP, Beekhuis WH, Melles GR. Endothelial cell density after posterior lamellar keratoplasty (Melles techniques): 3 years follow-up. Am J Ophthalmol. 2004;138(2):211–7. doi:10.1016/j.ajo.2004.02.016.
van Dooren BT, Mulder PG, Nieuwendaal CP, Beekhuis WH, Melles GR. Endothelial cell density after posterior lamellar keratoplasty: five- to seven-year follow-up. Am J Ophthalmol. 2007;144(3):471–3. doi:10.1016/j.ajo.2007.05.015.
Terry MA, Ousley PJ. Deep lamellar endothelial keratoplasty in the first United States patients: early clinical results. Cornea. 2001;20(3):239–43.
Terry MA, Ousley PJ. Replacing the endothelium without corneal surface incisions or sutures: the first United States clinical series using the deep lamellar endothelial keratoplasty procedure. Ophthalmology. 2003;110(4):755–64. doi:10.1016/s0161-6420(02)01939-5; discussion 64.
Ousley PJ, Terry MA. Stability of vision, topography, and endothelial cell density from 1 year to 2 years after deep lamellar endothelial keratoplasty surgery. Ophthalmology. 2005;112(1):50–7. doi:10.1016/j.ophtha.2004.07.028.
Terry MA. Endothelial keratoplasty: clinical outcomes in the two years following deep lamellar endothelial keratoplasty (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:530–63.
Terry MA, Ousley PJ. Rapid visual rehabilitation after endothelial transplants with deep lamellar endothelial keratoplasty (DLEK). Cornea. 2004;23(2):143–53.
Terry MA, Wall JM, Hoar KL, Ousley PJ. A prospective study of endothelial cell loss during the 2 years after deep lamellar endothelial keratoplasty. Ophthalmology. 2007;114(4):631–9. doi:10.1016/j.ophtha.2006.11.024.
Melles GR, Wijdh RH, Nieuwendaal CP. A technique to excise the Descemet membrane from a recipient cornea (descemetorhexis). Cornea. 2004;23(3):286–8.
Price Jr FW, Price MO. Descemet’s stripping with endothelial keratoplasty in 200 eyes: early challenges and techniques to enhance donor adherence. J Cataract Refract Surg. 2006;32(3):411–8. doi:10.1016/j.jcrs.2005.12.078.
Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea. 2006;25(8):886–9. doi:10.1097/01.ico.0000214224.90743.01.
Terry MA, Shamie N, Chen ES, Phillips PM, Hoar KL, Friend DJ. Precut tissue for Descemet’s stripping automated endothelial keratoplasty: vision, astigmatism, and endothelial survival. Ophthalmology. 2009;116(2):248–56. doi:10.1016/j.ophtha.2008.09.017.
Melles GR, Lander F, Rietveld FJ. Transplantation of Descemet’s membrane carrying viable endothelium through a small scleral incision. Cornea. 2002;21(4):415–8.
Gorovoy MS. DMEK complications. Cornea. 2014;33(1):101–4. doi:10.1097/ico.0000000000000023.
Guerra FP, Anshu A, Price MO, Giebel AW, Price FW. Descemet’s membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology. 2011;118(12):2368–73. doi:10.1016/j.ophtha.2011.06.002.
Monnereau C, Quilendrino R, Dapena I, Liarakos VS, Alfonso JF, Arnalich-Montiel F, et al. Multicenter study of descemet membrane endothelial keratoplasty: first case series of 18 surgeons. JAMA Ophthalmol. 2014. doi:10.1001/jamaophthalmol.2014.1710.
Terry MA. Endothelial keratoplasty: why aren’t we all doing Descemet membrane endothelial keratoplasty? Cornea. 2012;31(5):469–71. doi:10.1097/ICO.0b013e31823f8ee2.
Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology. 2008;115(9):1525–33. doi:10.1016/j.ophtha.2008.02.010.
Heidemann DG, Dunn SP, Chow CY. Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy. Cornea. 2008;27(2):161–7. doi:10.1097/ICO.0b013e31815b8304.
Pedersen IB, Ivarsen A, Hjortdal J. Graft rejection and failure following endothelial keratoplasty (DSAEK) and penetrating keratoplasty for secondary endothelial failure. Acta Ophthalmol. 2014. doi:10.1111/aos.12518.
Price MO, Gorovoy M, Price Jr FW, Benetz BA, Menegay HJ, Lass JH. Descemet’s stripping automated endothelial keratoplasty: three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology. 2013;120(2):246–51. doi:10.1016/j.ophtha.2012.08.007.
Hjortdal J, Pedersen IB, Bak-Nielsen S, Ivarsen A. Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for fuchs endothelial dystrophy. Cornea. 2013;32(5):e60–3. doi:10.1097/ICO.0b013e3182687ff3.
Ezon I, Shih CY, Rosen LM, Suthar T, Udell IJ. Immunologic graft rejection in descemet’s stripping endothelial keratoplasty and penetrating keratoplasty for endothelial disease. Ophthalmology. 2013;120(7):1360–5. doi:10.1016/j.ophtha.2012.12.036.
Anshu A, Price MO, Price Jr FW. Risk of corneal transplant rejection significantly reduced with Descemet’s membrane endothelial keratoplasty. Ophthalmology. 2012;119(3):536–40. doi:10.1016/j.ophtha.2011.09.019.
Phillips PM, Terry MA, Shamie N, Chen ES, Hoar KL, Stoeger C, et al. Descemet’s stripping automated endothelial keratoplasty (DSAEK) using corneal donor tissue not acceptable for use in penetrating keratoplasty as a result of anterior stromal scars, pterygia, and previous corneal refractive surgical procedures. Cornea. 2009;28(8):871–6. doi:10.1097/ICO.0b013e318199f8d7.
Groeneveld-van Beek EA, Lie JT, van der Wees J, Bruinsma M, Melles GR. Standardized ‘no-touch’ donor tissue preparation for DALK and DMEK: harvesting undamaged anterior and posterior transplants from the same donor cornea. Acta Ophthalmol. 2013;91(2):145–50. doi:10.1111/j.1755-3768.2012.02462.x.
Heindl LM, Riss S, Bachmann BO, Laaser K, Kruse FE, Cursiefen C. Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology. 2011;118(2):294–301. doi:10.1016/j.ophtha.2010.05.025.
Borderie VM, Boelle PY, Touzeau O, Allouch C, Boutboul S, Laroche L. Predicted long-term outcome of corneal transplantation. Ophthalmology. 2009;116(12):2354–60. doi:10.1016/j.ophtha.2009.05.009.
Borderie VM, Sandali O, Bullet J, Gaujoux T, Touzeau O, Laroche L. Long-term results of deep anterior lamellar versus penetrating keratoplasty. Ophthalmology. 2012;119(2):249–55. doi:10.1016/j.ophtha.2011.07.057.
Borderie VM, Guilbert E, Touzeau O, Laroche L. Graft rejection and graft failure after anterior lamellar versus penetrating keratoplasty. Am J Ophthalmol. 2011;151(6):1024–9e1. doi:10.1016/j.ajo.2011.01.007.
Reinhart WJ, Musch DC, Jacobs DS, Lee WB, Kaufman SC, Shtein RM. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology. Ophthalmology. 2011;118(1):209–18. doi:10.1016/j.ophtha.2010.11.002.
Cheng YY, Visser N, Schouten JS, Wijdh RJ, Pels E, van Cleynenbreugel H, et al. Endothelial cell loss and visual outcome of deep anterior lamellar keratoplasty versus penetrating keratoplasty: a randomized multicenter clinical trial. Ophthalmology. 2011;118(2):302–9. doi:10.1016/j.ophtha.2010.06.005.
Hirneiss C, Neubauer AS, Niedermeier A, Messmer EM, Ulbig M, Kampik A. Cost utility for penetrating keratoplasty in patients with poor binocular vision. Ophthalmology. 2006;113(12):2176–80. doi:10.1016/j.ophtha.2006.05.060.
Bose S, Ang M, Mehta JS, Tan DT, Finkelstein E. Cost-effectiveness of Descemet’s stripping endothelial keratoplasty versus penetrating keratoplasty. Ophthalmology. 2013;120(3):464–70. doi:10.1016/j.ophtha.2012.08.024.
Prabhu SS, Kaakeh R, Sugar A, Smith DG, Shtein RM. Comparative cost-effectiveness analysis of Descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in the United States. Am J Ophthalmol. 2013;155(1):45–53e1. doi:10.1016/j.ajo.2012.06.014.
van den Biggelaar FJ, Cheng YY, Nuijts RM, Schouten JS, Wijdh RJ, Pels E, et al. Economic evaluation of endothelial keratoplasty techniques and penetrating keratoplasty in the Netherlands. Am J Ophthalmol. 2012;154(2):272–81e2. doi:10.1016/j.ajo.2012.02.023.
van den Biggelaar FJ, Cheng YY, Nuijts RM, Schouten JS, Wijdh RJ, Pels E, et al. Economic evaluation of deep anterior lamellar keratoplasty versus penetrating keratoplasty in The Netherlands. Am J Ophthalmol. 2011;151(3):449–59e2. doi:10.1016/j.ajo.2010.09.012.
Koo TS, Finkelstein E, Tan D, Mehta JS. Incremental cost-utility analysis of deep anterior lamellar keratoplasty compared with penetrating keratoplasty for the treatment of keratoconus. Am J Ophthalmol. 2011;152(1):40–7e2. doi:10.1016/j.ajo.2011.01.017.
Beauchemin C, Brunette I, Boisjoly H, Freeman EE, Popescu M, Lachaine J. Economic impact of the advent of posterior lamellar keratoplasty in Montreal, Quebec. Can J Ophthalmol. 2010;45(3):243–51. doi:10.3129/i10-026.
Roe RH, Lass JH, Brown GC, Brown MM. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus. Cornea. 2008;27(9):1001–7. doi:10.1097/ICO.0b013e31817bb062.
Tan TE, Peh GS, George BL, Cajucom-Uy HY, Dong D, Finkelstein EA, et al. A cost-minimization analysis of tissue-engineered constructs for corneal endothelial transplantation. PLoS One. 2014;9(6):e100563. doi:10.1371/journal.pone.0100563.
Brown MM, Brown GC, Sharma S, Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol. 1999;10(3):221–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Brunette, I., Beauchemin, C., Lachaine, J. (2016). Economic Evaluation of Keratoplasty. In: Hjortdal, J. (eds) Corneal Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-24052-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-24052-7_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24050-3
Online ISBN: 978-3-319-24052-7
eBook Packages: MedicineMedicine (R0)